250 mg film-coated tablets
- Antineoplastic agents. Protein kinase inhibitors.
- GEFITINIB is a selective small molecule inhibitor of the epidermal growth factor receptor tyrosine kinase and is an effective treatment for patients with tumors with activating mutations of the EGFR tyrosine kinase domain regardless of line of therapy.
- GEFITINIB is approved for non-small cell lung cancer.